Original article
Efficacy of Short-term Postoperative Perfluoro-n-octane Tamponade for Pediatric Complex Retinal Detachment

https://doi.org/10.1016/j.ajo.2013.10.002Get rights and content

Purpose

To evaluate the efficacy of perfluoro-n-octane as a postoperative short-term tamponade after vitrectomy in pediatric cases with complex retinal detachment (RD) and proliferative vitreoretinopathy (PVR).

Design

Prospective, noncomparative, interventional case series.

Methods

The medical records of 10 eyes of 9 children (6 boys and 3 girls), whose age ranged from 3 months to 11 years, with a median of 7.5 months, were reviewed. The cause of the PVR was retinopathy of prematurity (7 eyes of 6 patients); familial exudative vitreoretinopathy; or tractional RD associated with congenital optic nerve anomalies,1 and persistent fetal vasculature. Perfluoro-n-octane was injected into the eyes at the primary surgery in 2 eyes and at the repeat surgeries in 8 eyes. The perfluoro-n-octane was removed after 1 to 4 postoperative weeks. The patients were followed for 5 to 43 months.

Results

At the last examination, the retinas were reattached in 8 eyes (80%). In the other two eyes, a retinal attachment was not obtained. Postoperatively, the best-corrected visual acuity improved from hand motion to 0.1 in 1 eye and could not be measured in the other 9 patients because of their ages. No apparent adverse events related to the use of perfluoro-n-octane were noted.

Conclusions

Although cautions should be exercised regarding potential mechanical retinal injuries by heavy liquids in the eye, short-term perfluoro-n-octane tamponade was effective in pediatric cases with severe PVR in which retinal reattachment is considered to be difficult with conventional gas or silicone oil tamponade.

Section snippets

Methods

The multicenter study was performed in accordance with the tenets of the Declaration of Helsinki. The Institutional Review Board of the Naha City Hospital and Sakai Hospital Kinki University Faculty of Medicine approved this prospective study before the beginning of the study, and a written informed consent was obtained from the parents of all patients. The protocol of this study was in compliance with Health Insurance Portability and Accountability Act requirements.

A perfluoro-n-octane

Case Report 1

Case 1 was an 8-year-old boy who was referred to us for the treatment of a rhegmatogenous RD involving the macula of the right eye. Fundus examinations revealed a retinal break in the inferior temporal retina of the right eye and a peripheral avascular area with fibrovascular membranes in the temporal retina in both eyes. These findings suggested that the patient had FEVR in both eyes. The decimal best-corrected visual acuity (BCVA) was 0.04 in the right eye. The retina was reattached by

Discussion

Postoperative perfluoro-n-octane tamponade was used for a short period in 10 eyes with pediatric complex RD, in which gas or silicone oil had been considered to be ineffective because the posterior proliferative changes were in the inferior retina. Perfluoro-n-octane tamponade was used because we believed that it would be difficult for children to maintain a prone position for any length of time. The perfluoro-n-octane was left in all of the eyes for 1 to 4 weeks, and the retinas remained

Ayako Imaizumi, MD, completed her residency in Ophthalmology at Osaka University Hospital. Currently she is the director of ophthalmology at Naha City Hospital and a postgraduate student at Graduate School of Medicine, University of the Ryukyus. Her field of interest includes surgical treatment of vitreoretinal disease such as diabetic retinopathy, retinal detachment, and retinopathy of prematurity.

References (14)

There are more references available in the full text version of this article.

Cited by (19)

  • Recurrent proliferative vitreoretinopathy in a patient with morning glory syndrome and intellectual disability

    2022, American Journal of Ophthalmology Case Reports
    Citation Excerpt :

    A third surgery was performed in which peripheral retinotomy and peeling of the proliferative membrane under perfluoro-n-octane (PFO) were followed by laser ablation on the peripheral retina to avoid the recurrent RD (Fig. 2B). PFO was retained to achieve better apposition of the retina and underlying RPE without maintaining face-down position.15 IOL was removed in the third surgery because of the severe PVR and fibrin formation on both anterior and posterior surfaces of the IOL.

  • Retinal detachment repair with perfluoro-N-octane endotamponade in an infant with juvenile X-linked retinoschisis

    2020, American Journal of Ophthalmology Case Reports
    Citation Excerpt :

    Given that these changes occurred in the inferior retina, and similar histological changes occurred in the superior retina of rabbit eyes injected with silicone oil, it was postulated that these effects may be mechanical rather than toxic. In their series, Imaizumi and colleagues noted no adverse effects in eyes receiving PFO tamponade for periods between 1 and 5 weeks.6 The appropriate duration for retained PFO, therefore, seems to be 1–2 weeks.

  • Bilateral rhegmatogenous retinal detachments from giant retinal tears in an infant with abusive head trauma and Stickler syndrome

    2020, American Journal of Ophthalmology Case Reports
    Citation Excerpt :

    The rate of anatomical success of retinal detachment surgery in pediatric cases is etiology-dependent with rhegmatogenous retinal detachments having better outcomes compared to tractional retinal detachments.11 The use of PFCL for short-term postoperative tamponade for retinal detachment in the pediatric population has previously been described in complex retinal detachment cases.13 PFCL was advantageous compared to silicone oil or gas tamponade in this infant as it allowed for supine positioning and eliminated the difficulty of prone positioning.

  • Autologous Retinal Transplant for Refractory Macular Holes: Multicenter International Collaborative Study Group

    2019, Ophthalmology
    Citation Excerpt :

    We also did not observe any cases of PFC toxicity, elevated intraocular pressure, intraocular inflammation (early or delayed), or flap displacement after PFC removal. Short-term use of intraocular PFC has been shown to be relatively safe.43–47 We observed late development of cystoid macular edema–like changes in the graft in several cases, usually 4 to 6 months after surgery.

View all citing articles on Scopus

Ayako Imaizumi, MD, completed her residency in Ophthalmology at Osaka University Hospital. Currently she is the director of ophthalmology at Naha City Hospital and a postgraduate student at Graduate School of Medicine, University of the Ryukyus. Her field of interest includes surgical treatment of vitreoretinal disease such as diabetic retinopathy, retinal detachment, and retinopathy of prematurity.

Shunji Kusaka, MD is a Professor of Ophthalmology at Sakai Hospital Kinki University Faculty of Medicine, Sakai, Japan. Dr Kusaka completed his residency in Ophthalmology at Osaka University and his fellowship training in vitreoretinal surgery at Osaka National Hospital. After finishing research fellowship program at University of Michigan, he continues clinical research in vitreoretinal diseases in Japan. His research interests include treatment of various vitreoretinal disorders, especially pediatric retinal diseases.

View full text